glp-1 alternatives to ozempic FDA approves Foundayo, an oral alternative Wegovy and glp-1 agonist weight loss medications

Reports that increased postprandial E

Exenatide associated renal failure

Are they covered by insurance

BMI, body mass index: CVD, cardiovascular disease

Even the FDA acknowledged that "patients and prescribers may still see intermittent and limited localized supply disruptions as the products move through the supply chain from the manufacturer and distributors to local pharmacies." The American Society of Health-System Pharmacists' shortage list continues to show both semaglutide and tirzepatide injection in shortage

The Importance of Electrolytes on GLP-1 Medications Electrolytes are a hot-button health issue these days